ANAPTYSBIO, INC. — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$235M
R&D
$136M
D&A
$559K
Operating Income
$48M
EBITDA
$48M
Interest Expense
—
Interest Income
—
Other Income/Expense
$-61M
Pretax Income
$-13M
Tax Provision
$164K
Net Income
$-13M
Operating Margin
20.4%
Net Margin
-5.6%
Effective Tax Rate
-1.3%
Deferred Tax Liabilities
$163K
DTA Valuation Allowance
$193M
Tax Credit Carryforwards
$33M
NOL Carryforwards
$154M
ETR (Continuing Operations)
-1.3%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
3.4%
Operating Lease Cost
$2K
Revenue YoY Variation
157.0%
Income YoY Variation
141.7%